Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,

    Updates to Anti-Coagulation Video Channel

    Not available for members in the UK, US, and Canada

    Three new videos have been added to the Anti-Coagulation Video Channel as part of a
    series of regular updates to this resource. In each video, experts discuss the use of
    novel oral anticoagulants in stroke and DVT. New clinical videos will be added
    regularly, so ensure you return often to make the most of this free resource.

    This resource has been developed in collaboration with Boehringer Ingelheim, who provided the videos.

  • ,

    New Type 2 Diabetes CME now available

    A new CME activity ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in
    Combination with Insulin’ has been added to the Type 2 Diabetes Learning Zone.
    Complete the five modules to enhance your understanding of the combination
    therapies available for treating type 2 diabetes.

  • ,COPD whats new ATS 2015

    ATS 2015 symposium materials added to
    COPD Knowledge Centre

    Speaker slides and a video from the Novartis-sponsored symposium ‘Are we gaining the
    maximum benefit from bronchodilators in COPD?’ have been added to the COPD Knowledge
    Centre. The session was held at the American Thoracic Society (ATS) conference 2015 to
    highlight the fundamental role of bronchodilators in COPD management, and presented
    key drug data including efficacy and safety of some of the latest COPD therapies.

  • ,Whats New CSU

    Updates to Chronic Spontaneous Urticaria
    Knowledge Centre

    Video presentations of faculty experts speaking at the 23rd World Congress of
    Dermatology (WCD) 2015 have been added to the Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre. Topics discussed include diagnosis, burden and an overall clinical
    picture of urticaria.

  • ,Hyperammonaemia Knowledge Centre

    Launch of Hyperammonaemia Knowledge Centre

    Could you recognise the signs and symptoms of hyperammonaemia?
    Healthcare professionals have FREE access to a new educational resource providing up
    to date disease awareness information, treatment options, video channel and resources
    to help them quickly identify and treat this potentially life-threatening condition.

Latest News

FDA issues complete response letter to sBLA for Opdivo (nivolumab) in untreated metastatic melanoma- BMS


The FDA has issued a Complete Response Letter for its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab), from BMS, as a single agent for the treatment of previously untreated patients, specifically those with BRAF V600 mutation ...

Assessment by IQWiG of Spiolto Respimat (tiotropium + olodaterol) in chronic obstructive pulmonary disease finds evidence of minor benefits- Boehringer


The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined in a dossier assessment whether the fixed-dose combination of Spiolto Respimat (tiotropium and olodaterol), from Boehringer, currently approved for maintenance ...

IQWiG assessment of Keytruda (pembrolizumab) finds considerable added benefit in advanced melanoma- Merck Inc


The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether Keytruda (pembrolizumab), from Merck Inc, offers an added benefit over the appropriate comparator therapy for adults with advanced ...

Initiation of rolling submission at FDA for pacritinib to treat Myelofibrosis- CTI BioPharma + Baxalta


CTI BioPharma Corp. announced the initiation of its rolling new drug application (NDA) to the FDA for pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1 and CSF1R. As part of the application, CTI BioPharma ...

NICE rejects Zykadia (ceritinib) to treat ALK+ metastatic non-small cell lung cancer.- Novartis


The National Institute for Health and Care Excellence (NICE) does not recommend Zykadia (ceritinib) from Novartis, for use in ALK+ metastatic non-small cell lung cancer patients who have progressed on or are intolerant to Xalkori (crizotinib). ...

Amgen files BLA for ABP 501 (adalimumab biosimilar) at FDA.


Amgen announced the submission of a Biologics License Application (BLA) with the FDA for ABP 501, a biosimilar candidate to Humira (adalimumab). Amgen believes this submission is the first adalimumab biosimilar application submitted to the FDA and ...

FDA issues Complete Response Letter to Invidior for its naloxone nasal spray to treat opioid overdose.


Indivior Inc., a subsidiary of Indivior PLC announced that it has received a Complete Response Letter from the FDA regarding its New Drug Application for naloxone nasal spray, an intranasal naloxone product candidate for the emergency treatment of ...

Recent Updates


Clinical Guidelines

Management of Obesity in Adults: European Clinical Practice Guidelines

British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia

Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015

Coeliac disease: recognition, assessment and management

Medical Journals

The Nature of Iron Deposits Differs between Symptomatic and Asymptomatic Carotid Atherosclerotic Plaques.

Free fatty acid as an outcome predictor of atrial fibrillation-associated stroke.

Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.

Decrease in B-Type natriuretic Peptide Levels and Successful Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors